ketotifen has been researched along with Obesity in 4 studies
Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| " In the present study, the effects of lime (Citrus aurantifolia) essential oils in reducing body weight, individually and in co-administration with ketotifen, an antihistaminic drug that causes weight gain, has been investigated using a mouse model." | 3.76 | Essential oil from Citrus aurantifolia prevents ketotifen-induced weight-gain in mice. ( Asnaashari, S; Delazar, A; Habibi, B; Hamedeyazdan, S; Nahar, L; Sarker, SD; Vasfi, R, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, X | 1 |
| Huang, Q | 1 |
| Wang, X | 1 |
| Deng, Z | 1 |
| Li, J | 1 |
| Yan, X | 1 |
| Jauhiainen, M | 1 |
| Metso, J | 1 |
| Libby, P | 1 |
| Liu, J | 1 |
| Shi, GP | 2 |
| El-Haggar, SM | 1 |
| Farrag, WF | 1 |
| Kotkata, FA | 1 |
| Asnaashari, S | 1 |
| Delazar, A | 1 |
| Habibi, B | 1 |
| Vasfi, R | 1 |
| Nahar, L | 1 |
| Hamedeyazdan, S | 1 |
| Sarker, SD | 1 |
| Wang, J | 1 |
1 trial available for ketotifen and Obesity
| Article | Year |
|---|---|
Effect of ketotifen in obese patients with type 2 diabetes mellitus.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Drug Interactions; Drug Therapy, Combination; Female; Huma | 2015 |
3 other studies available for ketotifen and Obesity
| Article | Year |
|---|---|
Dietary cholesterol is essential to mast cell activation and associated obesity and diabetes in mice.
Topics: Adipose Tissue; Animals; Anti-Allergic Agents; Anti-Asthmatic Agents; beta-N-Acetylhexosaminidases; | 2019 |
Essential oil from Citrus aurantifolia prevents ketotifen-induced weight-gain in mice.
Topics: Animals; Citrus aurantiifolia; Cyclohexenes; Gas Chromatography-Mass Spectrometry; Histamine H1 Anta | 2010 |
Mast cell stabilization: novel medication for obesity and diabetes.
Topics: Animals; Cromolyn Sodium; Diabetes Mellitus; Insulin Resistance; Ketotifen; Mast Cells; Mice; Obesit | 2011 |